Endometrial Functional Restoration and Pregnancy Success Prediction

Abstract

Endometrial functional restoration is a cornerstone of reproductive medicine, significantly impacting pregnancy outcomes in both natural and assisted conception cycles. This review synthesizes recent evidence on the mechanisms underlying endometrial receptivity, clinical predictors of pregnancy success, and advances in diagnostic and therapeutic strategies for endometrial dysfunction. We discuss epidemiology, pathophysiology, risk factors, clinical features, diagnostic modalities, management options, emerging therapies, and guideline-based recommendations, providing a comprehensive resource for clinicians aiming to optimize fertility outcomes through targeted endometrial assessment and intervention.

Introduction

The dynamic interplay between endometrial function and embryo implantation determines the success of human reproduction. Endometrial receptivity, defined by a transient window of optimal morphology and molecular signaling, is pivotal for embryo attachment and successful pregnancy. Despite advances in assisted reproductive technologies (ART), impaired endometrial function remains a significant cause of implantation failure. Understanding the clinical and mechanistic landscape of endometrial functional restoration is crucial for improving pregnancy success rates in subfertile and infertile women.

Epidemiology / Disease Burden

Endometrial dysfunction contributes to approximately 20–30% of infertility cases, affecting millions of women globally. The prevalence of thin endometrium (≤7mm) in ART cycles is reported at 2.4–5.0%, with associated lower pregnancy and live birth rates. Chronic endometritis, Asherman syndrome, and endometrial hypoplasia are notable conditions leading to suboptimal endometrial function. The burden is accentuated in women with repeated implantation failure (RIF), accounting for an estimated 10–15% of ART failures. Early identification and management of endometrial dysfunction are therefore essential to reduce the overall disease burden and improve reproductive outcomes.

Pathophysiology

Endometrial receptivity is orchestrated by hormonal cues, immune tolerance, vascular remodeling, and molecular crosstalk between the embryo and maternal tissues. Estrogen primes the endometrium during the proliferative phase, while progesterone induces secretory transformation, stromal decidualization, and expression of implantation markers such as leukemia inhibitory factor (LIF), integrins, and HOXA10. Dysfunctional endometrium may result from impaired angiogenesis, altered cytokine profiles, fibrosis, or chronic inflammation, ultimately leading to suboptimal receptivity. Molecular profiling studies have identified dysregulated gene expression in patients with RIF, highlighting the need for mechanism-based diagnostic tools and therapies.

Risk Factors

Several risk factors predispose women to endometrial dysfunction, including prior uterine surgery (curettage, myomectomy), intrauterine adhesions, pelvic inflammatory disease, chronic endometritis, hypoestrogenism, and prolonged use of intrauterine devices. Additional factors such as advanced maternal age, obesity, smoking, systemic autoimmune disorders, and repeated ART cycles also compromise endometrial receptivity. Genetic polymorphisms affecting hormone receptors and cytokines further modulate individual susceptibility to endometrial pathology.

Clinical Features

Clinically, endometrial dysfunction may present as infertility, recurrent pregnancy loss, irregular uterine bleeding, or persistent thin endometrium on ultrasound monitoring. In chronic endometritis, patients may exhibit abnormal uterine bleeding and pelvic discomfort, though many remain asymptomatic. In ART cycles, inadequate endometrial thickness or echogenicity on transvaginal ultrasound is a common indicator, prompting further evaluation of functional status.

Diagnosis

Diagnosis of endometrial dysfunction integrates clinical assessment with advanced imaging and molecular testing. Transvaginal ultrasound remains the primary tool for assessing endometrial thickness and pattern throughout the menstrual cycle. Doppler studies evaluate sub-endometrial blood flow, correlating with receptivity. Endometrial biopsy, evaluated histologically or via immunohistochemical markers (e.g., CD138 for plasma cells), aids in diagnosing chronic endometritis or confirming secretory transformation. The Endometrial Receptivity Array (ERA) utilizes transcriptomic profiling to identify the personalized window of implantation, enhancing precision in embryo transfer timing. Other emerging diagnostic modalities include proteomic and metabolomic analyses for functional assessment.

Treatment & Management

Management strategies target etiological factors and aim to restore endometrial functional capacity. Hysteroscopic adhesiolysis is the mainstay for intrauterine adhesions, while antibiotic therapy is indicated for chronic endometritis. Hormonal modulation using estrogen and progesterone supplementation supports endometrial proliferation and differentiation in hypoestrogenic states. Adjuvant therapies, including low-dose aspirin, pentoxifylline, granulocyte colony-stimulating factor (G-CSF), and platelet-rich plasma (PRP), are employed to enhance vascularization and regenerative potential. In ART, personalized embryo transfer protocols are increasingly adopted based on endometrial receptivity testing, optimizing implantation timing and success rates.

Recent Advances / Emerging Therapies

Recent advances focus on regenerative medicine and molecular interventions to restore endometrial function. Stem cell therapy, particularly with bone marrow-derived mesenchymal stem cells (MSCs), shows promise in promoting endometrial regeneration in Asherman syndrome and refractory thin endometrium. PRP intrauterine infusion enhances local growth factor delivery, stimulating tissue repair and angiogenesis. Molecular-targeted therapies, such as modulators of the Wnt/β-catenin and PI3K/Akt pathways, are under investigation to correct signaling defects in endometrial receptivity. Non-invasive omics-based profiling (transcriptomics, proteomics, metabolomics) is revolutionizing the prediction of endometrial readiness for implantation, paving the way for precision medicine approaches in reproductive care.

Guideline Recommendations

Current guidelines from the American Society for Reproductive Medicine (ASRM) and European Society of Human Reproduction and Embryology (ESHRE) emphasize comprehensive evaluation of the endometrium in women with infertility or recurrent implantation failure. Recommended approaches include transvaginal ultrasound monitoring, hysteroscopic assessment for structural anomalies, and targeted treatment of reversible etiologies such as infection or adhesions. The use of adjunctive therapies must be individualized, with emerging interventions considered within clinical trial settings. Personalized embryo transfer timing, informed by endometrial receptivity testing, is advocated in cases of repeated ART failure.

Conclusion

Endometrial functional restoration remains a critical determinant of pregnancy success in both natural and ART cycles. Advances in diagnostic and therapeutic modalities offer new hope for women with endometrial dysfunction, yet clinical application must be guided by robust evidence and individual patient profiles. Ongoing research into molecular mechanisms, regenerative therapies, and personalized medicine will further refine strategies for optimizing endometrial receptivity and improving reproductive outcomes.